trial · primary record
SCB-1019T
RSV Infection
| Phase | Phase 1, Phase 2 |
|---|---|
| Status | ACTIVE |
| Sponsor | Unknown |
| Enrolment | 612 |
| Primary completion | 2028-07 |
| Primary endpoint | To evaluate the safety and reactogenicity of SCB-1022 and SCB 1033 compared to SCB-1019T (Part 1 and Part 2) or Placebo (Part 3). |
| Registry ID | NCT06984094 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-10-28T02:31:55.862Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT06984094
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.